Showing results (641-650 of 779) with videos related to

Sort By:
Pageof 78
International Journal of Cardiology|May 31, 2017
Patterns and associations between DAPT cessation and 2-year clinical outcomes in left main/proximal LAD versus other PCI: Results from the Patterns of Non-Adherence to Dual Antiplatelet Therapy in Stented Patients (PARIS) registryJaya Chandrasekhar, Usman Baber, Samantha Sartori, et al.
Circulation|May 31, 2001
Point-of-care measured platelet inhibition correlates with a reduced risk of an adverse cardiac event after percutaneous coronary intervention: results of the GOLD (AU-Assessing Ultegra) multicenter studyS R Steinhubl, J D Talley, G A Braden, et al.
Scientific Reports|August 14, 2021
Patient-specific computational simulation of coronary artery bifurcation stentingShijia Zhao, Wei Wu, Saurabhi Samant, et al.
The American Journal of Cardiology|April 13, 2016
Relation Between Platelet Count and Platelet Reactivity to Thrombotic and Bleeding Risk: From the Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents StudyGennaro Giustino, Ajay J Kirtane, Philippe Généreux, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|January 10, 2020
Prasugrel use and clinical outcomes by age among patients undergoing PCI for acute coronary syndrome: from the PROMETHEUS studyJaya Chandrasekhar, Usman Baber, Samantha Sartori, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|January 17, 2020
The importance of the Heart Team evaluation before transcatheter aortic valve replacement: Results from the BRAVO-3 trialAnton Camaj, Bimmer E Claessen, Roxana Mehran, et al.
JACC. Cardiovascular Interventions|March 24, 2017
Incidence, Patterns, and Associations Between Dual-Antiplatelet Therapy Cessation and Risk for Adverse Events Among Patients With and Without Diabetes Mellitus Receiving Drug-Eluting Stents: Results From the PARIS RegistryMichela Faggioni, Usman Baber, Samantha Sartori, et al.
JACC. Cardiovascular Interventions|October 20, 2022
Position Statement on Vascular Access Safety for Percutaneous Devices in AMI Complicated by Cardiogenic ShockAbdulla A Damluji, Behnam Tehrani, Shashank S Sinha, et al.
Circulation. Cardiovascular Interventions|June 6, 2018
Incidence, Patterns, and Impact of Dual Antiplatelet Therapy Cessation Among Patients With and Without Chronic Kidney Disease Undergoing Percutaneous Coronary Intervention: Results From the PARIS Registry (Patterns of Non-Adherence to Anti-Platelet Regimens in Stented Patients)Usman Baber, Shawn X Li, Rebecca Pinnelas, et al.
Circulation. Cardiovascular Interventions|April 19, 2019
Influence of Baseline Anemia on Dual Antiplatelet Therapy Cessation and Risk of Adverse Events After Percutaneous Coronary InterventionMichela Faggioni, Usman Baber, Samantha Sartori, et al.
Pageof 78